Quizartinib in combination with decitabine and venetoclax for newly diagnosed and relapsed/refractory FLT3 -mutated AML.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Musa Yilmaz, Muharrem Muftuoglu, Courtney Denton DiNardo, Tapan M. Kadia, Marina Konopleva, Onyee Chan, Gautam Borthakur, Naveen Pemmaraju, Nicholas James Short, Yesid Alvarado Valero, Abhishek Maiti, Lucia Masarova, Guillermo Montalban-Bravo, Sanam Loghavi, Steven Mitchell Kornblau, David Andrew Sallman, Elias Jabbour, Farhad Ravandi-Kashani, Michael Andreeff, Naval Guastad Daver
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162534735